FDA Approves Updated Novavax COVID-19 Vaccine Targeting Omicron

The FDA recently approved an updated COVID-19 vaccine from Novavax that targets the Omicron variants.

The Novavax vaccine is a protein-based shot, unlike the mRNA vaccines from Pfizer and Moderna.

The Novavax vaccine appears similarly effective as mRNA vaccines at preventing COVID-19 infection and severe illness.

The Novavax shot may cause fewer side effects like sore arms and headaches compared to mRNA vaccines for some people.

It's fine to mix-and-match COVID-19 vaccines - if you got an mRNA vaccine before, you can get the Novavax booster.